About the XRAY Program & Ratings
FORCE has frequently observed situations where the media misrepresented cancer research. Some news articles feature attention-grabbing, hyped headlines and inaccurate content. Because scientific journals are hard to access and understand, people may turn to the popular press for information about cancer research to inform their medical decisions. We saw a need for a reliable source of breast cancer information in the headlines.
In response, FORCE developed “eXamining the Relevance of Articles for You” (XRAY). With initial funding from the CDC, we developed a program to review breast cancer topics reported in the media.
The XRAY content is produced by the FORCE Education Team which includes: Executive Director, Sue Friedman, DVM, Vice President of Education, Piri Welcsh, PhD, and Director of Education and Research, Kelly Owens, PhD. FORCE Vice President of Marketing, Karen Kramer leads our XRAY communication efforts. Dr. Welcsh is the XRAY Scientific Review Lead.
Our XRAY Team chooses media articles submitted to the team, new or practice-changing research, and articles that have received significant attention, stimulated discussion, or generated confusion in the patient community. Drs. Welcsh and Owens read the primary literature scientific literature. This literature is where scientists present their data and interpretations. They compare what was found in the original research and what the media article reported. Drs. Owens and Welcsh write up a summary on the original research findings and use our rating scale to rate the relevance of the research, the strength of the science and the accuracy of the media articles that covered the research (see below).
Every summary is reviewed and approved by a member of the FORCE Scientific Advisory Board, which consists of active researchers and clinicians in the fields of cancer, genetics, surgery, behavioral health, policy, and survivorship
Each XRAY review uses a series of meters to help users understand how the science affects their medical decisions and clinical care. XRAY articles are scored on each of the following categories:
- Scientific Strength
- Quality of Writing
- Research Cycle
Relevance is rated on a scale of 1-12 based on the criteria below. Points are converted to a percentage, which is reflected by a meter scale ranging from low to high.
- Topic: (0-2 points)
- Organism: (0 to 2 points)
- Clinical Utility: (0 to 2 points)
- Generalizability (0 to 2 points)
- Timeline to clinical relevance (0 to 4 points)
Scientific Strength is rated on a scale of 1-14 based on the criteria below. Points are converted to a percentage, which is reflected by a meter scale ranging from low to high.
- Research Design: (0 - 4 points)
- Analysis of study (0 - 7 points)
- Research context (0-1 point)
Quality of Writing is rated on a scale of 1-15 based on the criteria below. Points are converted to a percentage, which is reflected by a meter scale ranging from low to high.
- Depiction of Topic (0-4 points)
- Execution of Article (0-6 points)
- Factual Emphasis (0-5 points)
Research Timeline reflects the progress of the science on the research timeline.
- Lab Research
- Animal Research
- Human Research
- Post Approval
Media articles are rated on a 5-star rating scale.
To determine what rating the media article gets, XRAY looks at whether the writing is accurate:
- Did the headline match what the article claims?
- Did the article avoid exaggerating the research?
- Did the article take into account conflicting research?
XRAY also takes into account how well the article was executed:
- Did the story cite strong sources or experts in the field?
- Is the writing clear and easy to understand?
Finally, the rating looks at how scientifically accurate the media report is:
- Is the reporting factually correct?
- Was scientific terminology used correctly and explained well?
- Was the research covered in the story critically evaluated?
- Were all the statistics presented correct and not misleading?
Any part of a story that does not meet these criteria will result in lost points on the star rating scale.
FORCE has presented XRAYS and XRAY program results at national conferences and published articles in peer-reviewed journals.
Pugh Yi RH, Rezende L, Dearfield CT, Welcsh P, and Friedman SJ. Results of a pilot test of effects of an online resource on lay audience understanding of media reports on breast cancer research. Health Education Journal. April 2019
Pugh-Yi RH, Rezende, Dearfield CT, Owens KN, Welcsh PL, Friedman SJ. Effects of online resource to support laypersons’ understanding of media reports on breast cancer research. Dec. 8, 2018. San Antonio Breast Cancer Symposium Abstract P6-14-08.
American Public Health Association National Meeting, November 2015: Development, Implementation, and Evaluation of the eXamining Relevance of Articles to Young Survivors (XRAYS) Program to Summarize Recent Research Findings for Young Breast Cancer Survivors: Findings from the First Year
San Antonio Breast Cancer Symposium, December 2015: XRAYS (eXamining Relevance of Articles to Young Survivors) Program Survey of Information Needs and Media Use by Young Breast Cancer Survivors and Young Women at High Risk for Breast Cancer
Yi RHP, Rezende LF, Huynh J, Kramer K, Cranmer M, Schlager L, Dearfield CT, Friedman SJ. XRAYS (eXamining Relevance of Articles to Young Survivors) Program Survey of Information Needs and Media Use by Young Breast Cancer Survivors and Young Women at High-Risk for Breast Cancer. Health Commun. 2017 Sep 28:1-6. doi: 10.1080/10410236.2017.1372051.
The FORCE XRAY program thanks the members of our steering committees and our partner organizations: Asian Pacific Partners for Empowerment, Advocacy and Leadership; Young Survival Coalition, Living Beyond Breast Cancer, Sharsheret, Tigerlily Foundation, the Gulf States Young Breast Cancer Survivor Network, National African American Tobacco Prevention Network, National Alliance for Hispanic Health, National LGBT Cancer Network, Susan G. Komen and the Cancer Support Community for helping us establish and improve the XRAYS program.
The initial establishment of this program was supported by the Cooperative Agreement Number, DP005404, funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.
Thanks to generous support from Novartis, FORCE refined the XRAYS platform and process to focus on information and articles relevant to men and women living with metastatic breast cancer. The resulting eXaming the Relevance of Articles for You: Metastatic Breast Cancer (XRAY: MBC) helps people look behind the headlines to understand media articles related to metastatic breast cancer.